Can Benadryl (diphenhydramine) cause bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Benadryl (diphenhydramine) is not typically associated with causing bradycardia (abnormally slow heart rate), and its use is more commonly linked with tachycardia due to its anticholinergic effects. The medication works by blocking histamine H1 receptors and has significant anticholinergic properties that tend to increase heart rate rather than decrease it. At normal therapeutic doses (25-50mg every 4-6 hours, not exceeding 300mg daily for adults), cardiovascular effects are usually mild 1. However, in overdose situations or in certain sensitive individuals, particularly elderly patients or those with pre-existing cardiac conditions, paradoxical effects might occur.

According to a study published in 2025, diphenhydramine has a higher adverse side-effect profile, especially among children and older adults, which has led some countries to restrict access to first-generation antihistamines like diphenhydramine 2. Another study from 1995 found that diphenhydramine produced bradycardia followed by a transient hypertensive phase without affecting the QTc interval in guinea-pigs, but this effect is not typically seen in humans at therapeutic doses 3.

If you experience unusual heart rate changes while taking Benadryl, you should contact your healthcare provider. This medication can also cause drowsiness, dry mouth, blurred vision, and urinary retention due to its anticholinergic effects, which may be more concerning than any direct cardiac effects for most users. Given the availability of second-generation antihistamines with similar efficacy and fewer adverse effects, the use of diphenhydramine should be approached with caution, especially in vulnerable populations 2.

References

Research

Diphenhydramine: Time to Move on?

The journal of allergy and clinical immunology. In practice, 2022

Research

Diphenhydramine: It is time to say a final goodbye.

The World Allergy Organization journal, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.